
LANSOMID
Indication:
- Short term treatment of active duodenal ulcer.
- Maintenance of healed duodenal ulcers.
- Short term treatment of active benign gastric ulcers.
- Short term treatment of active erosive esophagitis.
- Maintenance of healing of erosive esophagitis.
- Pathological hypersecretory conditions including Zollinger- Ellison Syndrome.
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence.
- Gastro-esophageal Reflux Disease (GERD), Gastrointestinal Bleeding, Helicobacter Pylori Infection, Peptic Ulcer Disease, Hypersecretory conditions
Composition: Lansoprazole - 30mg
Pack Size: 14
Form: Capsule
Manufacturer: Middle East Pharmaceutical Co
Manufacturing Country: Jordan
Registration Number: 208016/03